Overview Fundamentals API Earnings EOD API Sample Code Pricing

Haemonetics Corporation (HAE NYSE) stock market data APIs

$91.15 -2.23(-2.4%) as of November 12, 2024
Price chart is built with Anychart

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Haemonetics Corporation Financial Data Overview

93.38
91.15
-
94.985
90.55
70.25-97.97
4 590 M
37.9253
50 224 K
1 361 M
1.12
0.321
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'HAE',
Type: 'Common Stock',
Name: 'Haemonetics Corporation',
Exchange: 'NYSE',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000C7TF41',
ISIN: NULL,
CUSIP: NULL,
CIK: '313143',
EmployerIdNumber: '04-2882273',
FiscalYearEnd: 'March',
IPODate: '1991-05-09',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Medical Instruments & Supplies',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Haemonetics Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 361 M
  • EBITDA 314 M
  • Earnings Per Share 2.41
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Haemonetics Corporation Earnings via APIs

  • Latest Release 2024-11-07
  • EPS/Forecast 1.07

Get Haemonetics Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com